Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands.

Ravensbergen SJ, Louka C, Ott A, Rossen JW, Cornish D, Pournaras S, Bathoorn E, Stienstra Y.

Antimicrob Resist Infect Control. 2019 Jan 7;8:6. doi: 10.1186/s13756-018-0455-5. eCollection 2019.

2.

Treatment for Buruli ulcer: the long and winding road to antimicrobials-first.

Omansen TF, Stienstra Y, van der Werf TS.

Cochrane Database Syst Rev. 2018 Dec 17;12:ED000128. doi: 10.1002/14651858.ED000128. No abstract available.

PMID:
30556580
3.

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data.

Daskapan A, Tran QTD, Cattaneo D, Gervasoni C, Resnati C, Stienstra Y, Bierman WFW, Kosterink JGW, van der Werf TS, Proost JH, Alffenaar JC, Touw DJ.

Ther Drug Monit. 2019 Feb;41(1):59-65. doi: 10.1097/FTD.0000000000000576.

4.

High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.

Omansen TF, Almeida D, Converse PJ, Li SY, Lee J, Stienstra Y, van der Werf T, Grosset JH, Nuermberger EL.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01478-18. doi: 10.1128/AAC.01478-18. Print 2019 Feb.

PMID:
30455239
5.

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs.

Daskapan A, Idrus LR, Postma MJ, Wilffert B, Kosterink JGW, Stienstra Y, Touw DJ, Andersen AB, Bekker A, Denti P, Hemanth Kumar AK, Jeremiah K, Kwara A, McIlleron H, Meintjes G, van Oosterhout JJ, Ramachandran G, Rockwood N, Wilkinson RJ, van der Werf TS, Alffenaar JC.

Clin Pharmacokinet. 2018 Nov 8. doi: 10.1007/s40262-018-0716-8. [Epub ahead of print] Review.

6.

National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries.

Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS; ESGITM Working Group on Vaccination in Migrants.

Travel Med Infect Dis. 2019 Jan - Feb;27:33-38. doi: 10.1016/j.tmaid.2018.10.011. Epub 2018 Oct 16.

7.

Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017.

Hargreaves S, Nellums LB, Ravensbergen SJ, Friedland JS, Stienstra Y, On Behalf Of The Esgitm Working Group On Vaccination In Migrants.

Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700772.

8.

Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: A retrospective cohort study between January 2014 - March 2016.

Beeres DT, Ravensbergen SJ, Heidema A, Cornish D, Vonk M, Wijnholds LD, Hendriks JJH, Kleinnijenhuis J, Omansen TF, Stienstra Y.

PLoS Negl Trop Dis. 2018 May 17;12(5):e0006401. doi: 10.1371/journal.pntd.0006401. eCollection 2018 May.

9.

Delayed versus standard assessment for excision surgery in patients with Buruli ulcer in Benin: a randomised controlled trial.

Wadagni AC, Barogui YT, Johnson RC, Sopoh GE, Affolabi D, van der Werf TS, de Zeeuw J, Kleinnijenhuis J, Stienstra Y.

Lancet Infect Dis. 2018 Jun;18(6):650-656. doi: 10.1016/S1473-3099(18)30160-9. Epub 2018 Apr 5.

PMID:
29605498
10.

Screening for infectious diseases of asylum seekers upon arrival: the necessity of the moral principle of reciprocity.

Beeres DT, Cornish D, Vonk M, Ravensbergen SJ, Maeckelberghe ELM, Boele Van Hensbroek P, Stienstra Y.

BMC Med Ethics. 2018 Mar 2;19(1):16. doi: 10.1186/s12910-018-0256-7.

11.

Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.

Ravensbergen SJ, Louka C, Lokate M, Bathoorn E, Pournaras S, van der Werf TS, de Lange WCM, Stienstra Y, Akkerman OW.

Am J Trop Med Hyg. 2018 Feb;98(2):376-378. doi: 10.4269/ajtmh.17-0544. Epub 2017 Dec 21.

12.

Risk factors contributing to a low darunavir plasma concentration.

Daskapan A, Stienstra Y, Kosterink JGW, Bierman WFW, van der Werf TS, Touw DJ, Alffenaar JC.

Br J Clin Pharmacol. 2018 Mar;84(3):456-461. doi: 10.1111/bcp.13464. Epub 2017 Dec 7.

13.

Methicillin Resistant Staphylococcus aureus Transmission in a Ghanaian Burn Unit: The Importance of Active Surveillance in Resource-Limited Settings.

Amissah NA, Buultjens AH, Ablordey A, van Dam L, Opoku-Ware A, Baines SL, Bulach D, Tetteh CS, Prah I, van der Werf TS, Friedrich AW, Seemann T, van Dijl JM, Stienstra Y, Stinear TP, Rossen JW.

Front Microbiol. 2017 Oct 6;8:1906. doi: 10.3389/fmicb.2017.01906. eCollection 2017.

14.

Epidemiology of Staphylococcus aureus in a burn unit of a tertiary care center in Ghana.

Amissah NA, van Dam L, Ablordey A, Ampomah OW, Prah I, Tetteh CS, van der Werf TS, Friedrich AW, Rossen JW, van Dijl JM, Stienstra Y.

PLoS One. 2017 Jul 13;12(7):e0181072. doi: 10.1371/journal.pone.0181072. eCollection 2017.

15.

Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting.

Daskapan A, Dijkema D, de Weerd DA, Bierman WFW, Kosterink JGW, van der Werf TS, Alffenaar JC, Stienstra Y.

Br J Clin Pharmacol. 2017 Oct;83(10):2325-2329. doi: 10.1111/bcp.13366. Epub 2017 Aug 1.

16.

Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands.

van Amsterdam MA, van Assen S, Sprenger HG, Wilting KR, Stienstra Y, Bierman WFW.

PLoS One. 2017 Jun 21;12(6):e0179539. doi: 10.1371/journal.pone.0179539. eCollection 2017.

17.

Virulence potential of Staphylococcus aureus isolates from Buruli ulcer patients.

Amissah NA, Chlebowicz MA, Ablordey A, Tetteh CS, Prah I, van der Werf TS, Friedrich AW, van Dijl JM, Stienstra Y, Rossen JW.

Int J Med Microbiol. 2017 Jun;307(4-5):223-232. doi: 10.1016/j.ijmm.2017.04.002. Epub 2017 Apr 19.

18.

High prevalence of MRSA and ESBL among asylum seekers in the Netherlands.

Ravensbergen SJ, Berends M, Stienstra Y, Ott A.

PLoS One. 2017 Apr 25;12(4):e0176481. doi: 10.1371/journal.pone.0176481. eCollection 2017.

19.

Neurological and functional recovery in tuberculosis patients with spinal cord injury in The Netherlands.

Wouda EMN, Stienstra Y, van der Werf TS, Kerstjens H, de Lange WCM, Coppes M, Kuijlen J, Tepper M, Akkerman OW.

NeuroRehabilitation. 2017;40(3):439-445. doi: 10.3233/NRE-161431.

PMID:
28222564
20.

Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.

Velink A, Woolley RJ, Phillips RO, Abass KM, van der Werf TS, Agumah E, de Zeeuw J, Klis S, Stienstra Y.

PLoS Negl Trop Dis. 2016 Dec 29;10(12):e0005261. doi: 10.1371/journal.pntd.0005261. eCollection 2016 Dec.

21.

Experiences of Pain and Expectations for Its Treatment Among Former Buruli Ulcer Patients.

Woolley RJ, Velink A, Phillips RO, Thompson WA, Abass KM, van der Werf TS, de Zeeuw J, Stienstra Y.

Am J Trop Med Hyg. 2016 Nov 2;95(5):1011-1015. Epub 2016 Sep 12.

22.

Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.

Klis S, Kingma RA, Tuah W, van der Werf TS, Stienstra Y.

Trop Med Int Health. 2016 Sep;21(9):1191-6. doi: 10.1111/tmi.12745. Epub 2016 Jul 26.

23.

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana.

Boakye-Appiah JK, Steinmetz AR, Pupulampu P, Ofori-Yirenkyi S, Tetteh I, Frimpong M, Oppong P, Opare-Sem O, Norman BR, Stienstra Y, van der Werf TS, Wansbrough-Jones M, Bonsu F, Obeng-Baah J, Phillips RO.

Int J Mycobacteriol. 2016 Jun;5(2):226-30. doi: 10.1016/j.ijmyco.2016.02.004. Epub 2016 Mar 8.

24.

The Application of Modern Dressings to Buruli Ulcers: Results from a Pilot Implementation Project in Ghana.

Velding K, Klis SA, Abass KM, van der Werf TS, Stienstra Y.

Am J Trop Med Hyg. 2016 Jul 6;95(1):60-2. doi: 10.4269/ajtmh.15-0378. Epub 2016 May 9.

25.

Poverty-Related Diseases Attack Simultaneously.

Barogui YT, Stienstra Y.

Am J Trop Med Hyg. 2016 May 4;94(5):939-40. doi: 10.4269/ajtmh.15-0823. No abstract available.

26.

High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015.

Ravensbergen SJ, Lokate M, Cornish D, Kloeze E, Ott A, Friedrich AW, van Hest R, Akkerman OW, de Lange WC, van der Werf TS, Bathoorn E, Stienstra Y.

PLoS One. 2016 May 4;11(5):e0154791. doi: 10.1371/journal.pone.0154791. eCollection 2016.

27.

Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.

Barogui YT, Klis SA, Johnson RC, Phillips RO, van der Veer E, van Diemen C, van der Werf TS, Stienstra Y.

PLoS Negl Trop Dis. 2016 Apr 20;10(4):e0004594. doi: 10.1371/journal.pntd.0004594. eCollection 2016 Apr.

28.

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae.

Gröschel MI, Omansen TF, de Lange W, van der Werf TS, Lokate M, Bathoorn E, Akkerman OW, Stienstra Y.

Am J Trop Med Hyg. 2016 Mar;94(3):517-8. doi: 10.4269/ajtmh.15-0690. Epub 2016 Jan 11.

29.

A cluster of tularaemia after contact with a dead hare in the Netherlands.

van de Wetering D, Oliveira dos Santos C, Wagelaar M, de Kleuver M, Koene MG, Roest HI, Sinha B, Tomaso H, Bierman WF, Stienstra Y.

Neth J Med. 2015 Dec;73(10):481-2.

30.

Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial.

Saktiawati AM, Sturkenboom MG, Stienstra Y, Subronto YW, Sumardi, Kosterink JG, van der Werf TS, Alffenaar JW.

J Antimicrob Chemother. 2016 Mar;71(3):703-10. doi: 10.1093/jac/dkv394. Epub 2015 Dec 11.

PMID:
26661397
31.

Assessment and Treatment of Pain during Treatment of Buruli Ulcer.

de Zeeuw J, Alferink M, Barogui YT, Sopoh G, Phillips RO, van der Werf TS, Loth S, Molenbuur B, Plantinga M, Ranchor AV, Stienstra Y.

PLoS Negl Trop Dis. 2015 Sep 24;9(9):e0004076. doi: 10.1371/journal.pntd.0004076. eCollection 2015.

32.

Molecular Characterization of Staphylococcus aureus Isolates Transmitted between Patients with Buruli Ulcer.

Amissah NA, Chlebowicz MA, Ablordey A, Sabat AJ, Tetteh CS, Prah I, van der Werf TS, Friedrich AW, van Dijl JM, Rossen JW, Stienstra Y.

PLoS Negl Trop Dis. 2015 Sep 11;9(9):e0004049. doi: 10.1371/journal.pntd.0004049. eCollection 2015.

33.

Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015.

Wilting KR, Stienstra Y, Sinha B, Braks M, Cornish D, Grundmann H.

Euro Surveill. 2015 Jul 30;20(30). pii: 21196.

34.

Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin.

Alferink M, de Zeeuw J, Sopoh G, Agossadou C, Abass KM, Phillips RO, Loth S, Jutten E, Barogui YT, Stewart RE, van der Werf TS, Stienstra Y, Ranchor AV.

PLoS One. 2015 Jun 1;10(6):e0119926. doi: 10.1371/journal.pone.0119926. eCollection 2015.

35.

The Never Ending Struggle Against Development of Drug Resistance.

Daskapan A, Stienstra Y, Akkerman OW, de Lange WC, Kosterink JG, van der Werf TS, Alffenaar JW.

Clin Infect Dis. 2015 Jul 1;61(1):137-8. doi: 10.1093/cid/civ238. Epub 2015 Mar 25. No abstract available.

PMID:
25810289
36.

In-vitro activity of avermectins against Mycobacterium ulcerans.

Omansen TF, Porter JL, Johnson PD, van der Werf TS, Stienstra Y, Stinear TP.

PLoS Negl Trop Dis. 2015 Mar 5;9(3):e0003549. doi: 10.1371/journal.pntd.0003549. eCollection 2015 Mar.

37.

Genetic diversity of Staphylococcus aureus in Buruli ulcer.

Amissah NA, Glasner C, Ablordey A, Tetteh CS, Kotey NK, Prah I, van der Werf TS, Rossen JW, van Dijl JM, Stienstra Y.

PLoS Negl Trop Dis. 2015 Feb 6;9(2):e0003421. doi: 10.1371/journal.pntd.0003421. eCollection 2015 Feb.

38.

The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection.

Daskapan A, de Lange WC, Akkerman OW, Kosterink JG, van der Werf TS, Stienstra Y, Alffenaar JW.

Eur Respir J. 2015 Feb;45(2):569-71. doi: 10.1183/09031936.00142614. No abstract available.

39.

Raltegravir and rifampicin in patients with HIV and tuberculosis.

Klis S, Daskapan A, Akkerman OW, Alffenaar JW, Stienstra Y.

Lancet Infect Dis. 2014 Nov;14(11):1046-1047. doi: 10.1016/S1473-3099(14)70977-6. Epub 2014 Oct 19. No abstract available.

PMID:
25444405
40.

Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin.

de Zeeuw J, Douwstra M, Omansen TF, Sopoh GE, Johnson C, Phillips RO, Alferink M, Saunderson P, Van der Werf TS, Dijkstra PU, Stienstra Y.

PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3254. doi: 10.1371/journal.pntd.0003254. eCollection 2014.

41.

Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin.

de Zeeuw J, Omansen TF, Douwstra M, Barogui YT, Agossadou C, Sopoh GE, Phillips RO, Johnson C, Abass KM, Saunderson P, Dijkstra PU, van der Werf TS, Stienstra Y.

PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3303. doi: 10.1371/journal.pntd.0003303. eCollection 2014 Nov. Erratum in: PLoS Negl Trop Dis. 2014 Dec;8(12):e3418. Stientstra, Ymkje [corrected to Stienstra, Ymkje].

42.

Buruli ulcer control in a highly endemic district in Ghana: role of community-based surveillance volunteers.

Abass KM, van der Werf TS, Phillips RO, Sarfo FS, Abotsi J, Mireku SO, Thompson WN, Asiedu K, Stienstra Y, Klis SA.

Am J Trop Med Hyg. 2015 Jan;92(1):115-7. doi: 10.4269/ajtmh.14-0405. Epub 2014 Oct 20.

43.

Contribution of the community health volunteers in the control of Buruli ulcer in Bénin.

Barogui YT, Sopoh GE, Johnson RC, de Zeeuw J, Dossou AD, Houezo JG, Chauty A, Aguiar J, Agossadou D, Edorh PA, Asiedu K, van der Werf TS, Stienstra Y.

PLoS Negl Trop Dis. 2014 Oct 2;8(10):e3200. doi: 10.1371/journal.pntd.0003200. eCollection 2014 Oct.

44.

Compliance with antimicrobial therapy for buruli ulcer.

Klis S, Kingma R, Tuah W, Stienstra Y, van der Werf TS.

Antimicrob Agents Chemother. 2014 Oct;58(10):6340. doi: 10.1128/AAC.03763-14. No abstract available.

45.

Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.

Klis S, Ranchor A, Phillips RO, Abass KM, Tuah W, Loth S, Velding K, van der Werf TS, Stienstra Y.

PLoS Negl Trop Dis. 2014 Jul 10;8(7):e2964. doi: 10.1371/journal.pntd.0002964. eCollection 2014 Jul.

46.

Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice.

Klis S, van der Werf TS, Phillips RO, Sarfo FS, Wansbrough-Jones M, Stienstra Y.

AIDS. 2014 Mar 13;28(5):797-8. doi: 10.1097/QAD.0000000000000146. No abstract available.

PMID:
24979651
47.

Management of BU-HIV co-infection.

O'Brien DP, Ford N, Vitoria M, Christinet V, Comte E, Calmy A, Stienstra Y, Eholie S, Asiedu K.

Trop Med Int Health. 2014 Sep;19(9):1040-7. doi: 10.1111/tmi.12342. Epub 2014 Jun 20. Review.

48.

Wound care in Buruli ulcer disease in Ghana and Benin.

Velding K, Klis SA, Abass KM, Tuah W, Stienstra Y, van der Werf T.

Am J Trop Med Hyg. 2014 Aug;91(2):313-8. doi: 10.4269/ajtmh.13-0255. Epub 2014 Jun 9.

49.

Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.

Klis S, Stienstra Y, Phillips RO, Abass KM, Tuah W, van der Werf TS.

PLoS Negl Trop Dis. 2014 Mar 13;8(3):e2739. doi: 10.1371/journal.pntd.0002739. eCollection 2014 Mar.

50.

Trimethoprim/sulfamethoxazole susceptibility of Mycobacterium tuberculosis.

Alsaad N, van der Laan T, van Altena R, Wilting KR, van der Werf TS, Stienstra Y, van Soolingen D, Alffenaar JW.

Int J Antimicrob Agents. 2013 Nov;42(5):472-4. doi: 10.1016/j.ijantimicag.2013.07.011. Epub 2013 Aug 23. No abstract available.

PMID:
24035198

Supplemental Content

Loading ...
Support Center